Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1388 | 7661 | 33.3 | 69% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
385 | 29018 | ANTIPHOSPHOLIPID SYNDROME//SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID ANTIBODIES |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2110 | 2286 | ANTI DNA//ANTI DNA ANTIBODIES//ANTI DSDNA ANTIBODIES |
3307 | 1938 | MIXED CONNECTIVE TISSUE DISEASE//LA SS B//RO SS A |
7689 | 1260 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
7914 | 1236 | CUTANEOUS LUPUS ERYTHEMATOSUS//DISCOID LUPUS ERYTHEMATOSUS//SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
18010 | 509 | ANTINUCLEAR ANTIBODIES//INDIRECT IMMUNOFLUORESCENCE//ANA |
25283 | 237 | ROS DNA//ROS HSA//JN MED |
27117 | 195 | HEPATOMA DERIVED GROWTH FACTOR//HDGF//HEPATOMA DERIVED GROWTH FACTOR HDGF |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONGENITAL HEART BLOCK | Author keyword | 200 | 75% | 2% | 143 |
2 | NEONATAL LUPUS | Author keyword | 114 | 75% | 1% | 82 |
3 | NEONATAL LUPUS ERYTHEMATOSUS | Author keyword | 108 | 87% | 1% | 53 |
4 | HEPATOMA DERIVED GROWTH FACTOR | Author keyword | 82 | 92% | 0% | 33 |
5 | CUTANEOUS LUPUS ERYTHEMATOSUS | Author keyword | 77 | 62% | 1% | 80 |
6 | ANTI DNA | Author keyword | 77 | 61% | 1% | 82 |
7 | ANTINUCLEAR ANTIBODIES | Author keyword | 62 | 33% | 2% | 155 |
8 | MIXED CONNECTIVE TISSUE DISEASE | Author keyword | 62 | 42% | 1% | 113 |
9 | ANTI DNA ANTIBODIES | Author keyword | 59 | 46% | 1% | 95 |
10 | LA SS B | Author keyword | 53 | 89% | 0% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CONGENITAL HEART BLOCK | 200 | 75% | 2% | 143 | Search CONGENITAL+HEART+BLOCK | Search CONGENITAL+HEART+BLOCK |
2 | NEONATAL LUPUS | 114 | 75% | 1% | 82 | Search NEONATAL+LUPUS | Search NEONATAL+LUPUS |
3 | NEONATAL LUPUS ERYTHEMATOSUS | 108 | 87% | 1% | 53 | Search NEONATAL+LUPUS+ERYTHEMATOSUS | Search NEONATAL+LUPUS+ERYTHEMATOSUS |
4 | HEPATOMA DERIVED GROWTH FACTOR | 82 | 92% | 0% | 33 | Search HEPATOMA+DERIVED+GROWTH+FACTOR | Search HEPATOMA+DERIVED+GROWTH+FACTOR |
5 | CUTANEOUS LUPUS ERYTHEMATOSUS | 77 | 62% | 1% | 80 | Search CUTANEOUS+LUPUS+ERYTHEMATOSUS | Search CUTANEOUS+LUPUS+ERYTHEMATOSUS |
6 | ANTI DNA | 77 | 61% | 1% | 82 | Search ANTI+DNA | Search ANTI+DNA |
7 | ANTINUCLEAR ANTIBODIES | 62 | 33% | 2% | 155 | Search ANTINUCLEAR+ANTIBODIES | Search ANTINUCLEAR+ANTIBODIES |
8 | MIXED CONNECTIVE TISSUE DISEASE | 62 | 42% | 1% | 113 | Search MIXED+CONNECTIVE+TISSUE+DISEASE | Search MIXED+CONNECTIVE+TISSUE+DISEASE |
9 | ANTI DNA ANTIBODIES | 59 | 46% | 1% | 95 | Search ANTI+DNA+ANTIBODIES | Search ANTI+DNA+ANTIBODIES |
10 | LA SS B | 53 | 89% | 0% | 24 | Search LA+SS+B | Search LA+SS+B |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONGENITAL HEART BLOCK | 263 | 61% | 4% | 279 |
2 | NEONATAL LUPUS | 228 | 67% | 3% | 203 |
3 | SMALL CYTOPLASMIC RIBONUCLEOPROTEINS | 156 | 90% | 1% | 69 |
4 | SS A RO | 134 | 79% | 1% | 85 |
5 | RO SS A | 131 | 66% | 2% | 122 |
6 | DIAGNOSED IN UTERO | 82 | 92% | 0% | 33 |
7 | ANTI DNA ANTIBODIES | 79 | 36% | 2% | 180 |
8 | CUTANEOUS LUPUS | 79 | 61% | 1% | 84 |
9 | EXTRACTABLE NUCLEAR ANTIGENS | 77 | 84% | 1% | 42 |
10 | NEONATAL LUPUS ERYTHEMATOSUS | 73 | 82% | 1% | 42 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METHODS-A COMPANION TO METHODS IN ENZYMOLOGY | 1 | 11% | 0% | 8 |
2 | DIAGNOSTIC AND CLINICAL IMMUNOLOGY | 1 | 11% | 0% | 7 |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies | 2014 | 38 | 43 | 79% |
Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks | 2015 | 3 | 36 | 67% |
Automated antinuclear immunofluorescence antibody screening: A comparative study of six computer-aided diagnostic systems | 2014 | 11 | 23 | 87% |
Antibodies to DNA | 1998 | 392 | 60 | 60% |
Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) | 2013 | 17 | 40 | 83% |
A systematic review of drug-induced subacute cutaneous lupus erythematosus | 2011 | 36 | 36 | 92% |
Molecular mechanisms of congenital heart block | 2014 | 5 | 61 | 87% |
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis | 2012 | 22 | 16 | 88% |
GENETIC AND STRUCTURAL EVIDENCE FOR ANTIGEN SELECTION OF ANTI-DNA ANTIBODIES | 1994 | 351 | 81 | 58% |
Systemic lupus erythematosus | 1996 | 474 | 26 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RHEUMAT DIS MOL MED | 11 | 100% | 0.1% | 6 |
2 | BLOOMSBURY RHEUMATOL UNIT | 9 | 32% | 0.3% | 23 |
3 | ARTHRIT IMMUNOL PROGRAM | 6 | 17% | 0.4% | 29 |
4 | DEV OFF 151 | 5 | 55% | 0.1% | 6 |
5 | AUTOINMUNIDAD | 4 | 50% | 0.1% | 6 |
6 | NEUROBIOL PAIN THER EUT SECT | 4 | 23% | 0.2% | 14 |
7 | FETAL CARDIAC PROGRAM | 3 | 35% | 0.1% | 8 |
8 | FLINDERS PROTE IL | 3 | 57% | 0.1% | 4 |
9 | HEPATOBILIARY PANCREAT MED | 3 | 31% | 0.1% | 9 |
10 | DIAGNOST MICROBIOL TRANSFUS MED | 3 | 100% | 0.0% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000028794 | SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS |
2 | 0.0000014708 | DERMATOMYOSITIS//POLYMYOSITIS//INCLUSION BODY MYOSITIS |
3 | 0.0000014125 | SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION |
4 | 0.0000013044 | SYSTEMIC SCLEROSIS//SCLERODERMA//RAYNAUDS PHENOMENON |
5 | 0.0000011546 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |
6 | 0.0000009569 | CONCEPTUAL IMMUNOL GRP//SEQUENCE UNIQUENESS//ARTIFICIAL IMMUNE SYSTEMS |
7 | 0.0000008714 | EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX |
8 | 0.0000008432 | TINU SYNDROME//ACUTE INTERSTITIAL NEPHRITIS//PROPYLTHIOURACIL |
9 | 0.0000007840 | DRY EYE//SJOGRENS SYNDROME//XEROSTOMIA |
10 | 0.0000007406 | APPARENT EQUILIBRIUM CONSTANTS//TRANSFORMED THERMODYNAMIC PROPERTIES//TRANSFORMED GIBBS ENERGY |